Arnuity ellipta and Xopenex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Arnuity ellipta (fluticasone furoate) and Xopenex (levalbuterol hydrochloride). Common drug interactions include urinary tract infection among females and upper-airway cough syndrome among males.

The phase IV clinical study analyzes what interactions people have when they take Arnuity ellipta and Xopenex. It is created by eHealthMe based on reports of 41 people who take the same drugs from the FDA, and is updated regularly.

What is Arnuity ellipta?

Arnuity ellipta has active ingredients of fluticasone furoate. eHealthMe is studying from 3,482 Arnuity ellipta users. Check the latest studies of Arnuity ellipta.

What is Xopenex?

Xopenex has active ingredients of levalbuterol hydrochloride. It is often used in asthma. eHealthMe is studying from 13,816 Xopenex users. Check the latest studies of Xopenex.



On Jul, 27, 2026

41 people who take Arnuity ellipta and Xopenex together, and have interactions are studied.

Arnuity ellipta and Xopenex drug interactions.

What are the common drug interactions of Arnuity Ellipta and Xopenex, by gender? *:

female:

  1. Urinary tract infection
  2. Vomiting
  3. Cellulitis (infection under the skin)
  4. Fall
  5. Headache (pain in head)
  6. Sinusitis (inflammation of sinus)
  7. Palpitations (feelings or sensations that your heart is pounding or racing)
  8. Anaemia (lack of blood)
  9. Diarrhoea
  10. Nausea (feeling of having an urge to vomit)

male:

  1. Upper-airway cough syndrome
  2. Balance disorder
  3. Chest discomfort
  4. Chest pain
  5. Death
  6. Dizziness
  7. Drug ineffective
  8. Dyspnoea (difficult or laboured respiration)
  9. Pulmonary oedema (fluid accumulation in the lungs)

What are the common drug interactions of Arnuity Ellipta and Xopenex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Sinusitis (inflammation of sinus)
  2. Liver disorder (liver diseases)
  3. Malaise (a feeling of general discomfort or uneasiness)

30-39:

  1. Upper-airway cough syndrome
  2. Chest discomfort
  3. Chest pain
  4. Drug ineffective
  5. Dyspnoea (difficult or laboured respiration)
  6. Pulmonary oedema (fluid accumulation in the lungs)

40-49:

  1. Chest discomfort
  2. Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
  3. Arthralgia (joint pain)
  4. Balance disorder
  5. Blood pressure increased
  6. Confusional state
  7. Dizziness
  8. Dyspnoea (difficult or laboured respiration)
  9. Fibromyalgia (a long-term condition which causes pain all over the body)
  10. Heart rate increased

50-59:

  1. Pyrexia (fever)
  2. Headache (pain in head)
  3. Diarrhoea
  4. Drug intolerance (drug sensitivity)
  5. Nausea (feeling of having an urge to vomit)
  6. Palpitations (feelings or sensations that your heart is pounding or racing)
  7. Vomiting
  8. Chills (felling of cold)
  9. Migraine (headache)
  10. Pain

60+:

  1. Urinary tract infection
  2. Cellulitis (infection under the skin)
  3. Intervertebral disc disorder (spinal disc disorder)
  4. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
  5. Weight increased
  6. Fatigue (feeling of tiredness)
  7. Osteoporosis (bones weak and more likely to break)
  8. Blood pressure inadequately controlled
  9. Dehydration (dryness resulting from the removal of water)
  10. Increased tendency to bruise (increased tendency to injure the underlying soft tissue or bone)

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 6 people, 14.63%
  2. Primary Immunodeficiency Syndrome: 5 people, 12.20%
  3. Immunodeficiency: 4 people, 9.76%
  4. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 7.32%

* Approximation only. Some reports may have incomplete information.

Do you take Arnuity ellipta and Xopenex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Arnuity ellipta and Xopenex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Arnuity ellipta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Xopenex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Arnuity ellipta and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Xopenex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on fluticasone furoate and levalbuterol hydrochloride (the active ingredients of Arnuity ellipta and Xopenex, respectively), and Arnuity ellipta and Xopenex (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: